// App-Quantinova.ai

321.0 : Temozolomide in grade III neuroendocrine neoplasms (G3 NENs): A multicenter retrospective review.

Researchers

Presenter

  • David Chan

Principal Investigators

  • Emily K. Bergsland

  • Jennifer A. Chan

  • Rujuta Gadgil

  • Thorvardur Ragnar Halfdanarson

  • Kathleen Hornbacker

  • Virginia Kelly

  • Pamela L. Kunz

  • Patrick Walsh McGarrah

  • Nitya Prabhakar Raj

  • Diane Lauren Reidy

  • Alia Thawer

  • Julia Whitman

  • Linda Wu

  • Simron Singh

Medical Centers

  • Sunnybrook Odette Cancer Centre, Toronto, ON, Canada

  • University of California, San Francisco, San Francisco, CA

  • Dana-Farber Cancer Institute, Boston, MA

  • Mayo Clinic, Rochester, MN

  • Stanford Cancer Clinical Trials Office, Palo Alto, CA

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Stanford School of Medicine, Stanford, CA

  • New York Presbyterian Weill Cornell Medical Center, New York, NY

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Temozolomide

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved